A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
NCT03356977
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
137
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Crisaborole ointment 2%
Sponsor
Pfizer